Levels Raises $10M in Extended Funding Round
The metabolic health software startup is using crowdfunding to help fuel its growth
Levels, a software startup co-founded in 2019 by longevity expert Dr. Casey Means, which uses artificial intelligence for meal monitoring and personalized insights based on biomarkers, has announced a $10 million Series A extension.
The round included $3 million in crowdfunding from over 2,000 investors and follows a $38 million Series A in 2022. Crowdfunding has been part of Levels’ mission as it grows, having previously raised $5 million of its Series A in a crowdfunding round that saw over 1,400 Levels members participate.
In addition to Dr. Means, the startup has other notable co-founders on board as it seeks to solve the metabolic health crisis, including former SpaceX and Hyperloop engineer Josh Clemente and David Flinner and Andrew Conner, formerly of Google.
Since its inception, Levels has assisted over 60,000 members in improving their metabolic health through real-time blood-sugar monitoring with an optional continuous glucose monitor that syncs to an app. From there, members can discover valuable glucose data and insights into how their lifestyle choices (such as nutrition, sleep and exercise) affect their health.
Levels members can also go beyond glucose readings and get tested for health markers such as HbA1c, fasting insulin, ApoB, triglycerides and uric acid, accessing the results on the app.
Although consumers have become increasingly health conscious, the number of Americans who are metabolically unhealthy is staggering, with more than a third of Americans having prediabetes. While grim, it’s a number that can change, say Levels’ founders.
“Consumers want to take their health into their own hands, and Levels’ expertise, data science, and guidance through the app allows them to see real improvement, whether or not they’re wearing a CGM,” Clemente said. “This is how we start to address metabolic health at scale.”
While having access to comprehensive and personalized health data is key to improving metabolic health, Levels takes it a step further with AI-powered food logging, macro tracking and an accountability feature so users can understand the most optimal choices.
“Simply tracking meals isn’t enough,” Levels CEO Corcos said. “That’s why Levels goes beyond basic food logging to actually show you how these choices affect your health and what you should do to achieve your goals. Our members see results.”
The startup is also conducting a large-scale Institutional Review Board-approved research study to better understand the glucose patterns of people of various ages, genders and races.
“Levels is an immediate answer for the metabolic health crisis, the defining health crisis of our era,” stated Marc Andreessen, Levels investor and co-founder and general partner at a16z. “Both the health of our people and the fiscal solvency of our country are at stake — Levels is a case study of the application of technology to both.”
